NYSE:NVTA • US46185L1035
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INVITAE CORP (NVTA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-11-13 | Piper Sandler | Maintains | Underweight -> Underweight |
| 2023-10-23 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-10-20 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-08-15 | Piper Sandler | Maintains | Underweight -> Underweight |
| 2023-07-24 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-07-21 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-05-15 | Raymond James | Downgrade | Market Perform -> Underperform |
| 2023-05-11 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-03-03 | Piper Sandler | Maintains | Underweight |
| 2023-01-31 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2022-11-09 | SVB Leerink | Maintains | Market Perform |
| 2022-08-25 | Credit Suisse | Initiate | Underperform |
| 2022-08-18 | Piper Sandler | Maintains | Underweight |
| 2022-08-10 | SVB Leerink | Maintains | Market Perform |
| 2022-08-10 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-07-26 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-07-21 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2022-07-19 | Benchmark | Downgrade | Buy -> Hold |
| 2022-07-19 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-07-19 | Cowen & Co. | Maintains | Outperform |
| 2022-06-13 | Benchmark | Maintains | Buy |
| 2022-06-03 | Piper Sandler | Initiate | Underweight |
| 2022-05-05 | Raymond James | Maintains | Outperform |
| 2022-05-04 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-04-19 | Goldman Sachs | Maintains | Neutral |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 279.6M 28.97% | 460.4M 64.66% | 516.3M 12.14% | 494.04M -4.31% | 534.36M 8.16% | 587.18M 9.88% | 608.63M 3.65% | |
| EBITDA YoY % growth | -590.55M -159.14% | -311.13M 47.32% | -556.03M -78.71% | -183.03M 67.08% | -170.646M 6.77% | -136.743M 19.87% | -89.862M 34.28% | |
| EBIT YoY % growth | -629.6M -157.93% | -391.6M 37.80% | -698.1M -78.27% | -306.405M 56.11% | -261.608M 14.62% | -240.776M 7.96% | -263.364M -9.38% | |
| Operating Margin | -225.18% | -85.06% | -135.21% | -62.02% | -48.96% | -41.01% | -43.27% | |
| EPS YoY % growth | -2.82 -22.08% | -3.20 -13.48% | -2.22 30.63% | -1.04 53.25% | -0.90 12.90% | -0.76 15.86% | -0.86 -12.64% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 10.00% | -0.30 18.68% | -0.38 -27.50% | -0.24 -139.70% | -0.24 20.00% | -0.26 15.25% | -0.34 12.00% | -0.19 19.15% | -0.28 -12.50% |
| Revenue Q2Q % growth | 119.6M -2.37% | 122.2M 4.09% | 129.08M 7.12% | 129.95M 7.22% | 124.64M 4.21% | 124.44M 1.83% | 132.8M 2.88% | 133.01M 2.35% | 124.64M |
| EBITDA Q2Q % growth | -35.292M -101.51% | -39.678M 54.83% | -62.424M 18.76% | -22.746M -809.84% | -24.888M 29.48% | -28.587M 27.95% | -22.843M 63.41% | -24.193M -6.36% | -20.923M 15.93% |
| EBIT Q2Q % growth | -75.99M -103.47% | -75.531M 38.49% | -99.093M 31.89% | -59.415M 42.26% | -71.145M 6.38% | -74.46M 1.42% | -99.96M -0.87% | -58.14M 2.15% | -80.58M -13.26% |
All data in USD
13 analysts have analysed NVTA and the average price target is 0.72 USD. This implies a price increase of 712.79% is expected in the next year compared to the current price of 0.0891.
INVITAE CORP (NVTA) will report earnings on 2024-02-21, after the market close.
The consensus EPS estimate for the next earnings of INVITAE CORP (NVTA) is -0.31 USD and the consensus revenue estimate is 119.60M USD.
The expected long term growth rate for INVITAE CORP (NVTA) is 3.75%.